Wen Bin Wang
Net worth: 22 M $ as of 2024-05-30
Network origin in Wen Bin Wang first degree
Entity | Entity type | Industry | |
---|---|---|---|
The Second Military Medical University
17
| College/University | Other Consumer Services | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Wen Bin Wang via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
BEVERLY JCG LTD. | Wholesale Distributors | Chief Executive Officer | |
HK EBUS CORPORATION | Integrated Oil | Chief Executive Officer | |
SINOPHARM GROUP CO. LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SINARMAS LAND LIMITED | Real Estate Development | Chief Operating Officer | |
Tongji University | College/University | Corporate Officer/Principal Masters Business Admin | |
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Pharmaceuticals: Major | Corporate Officer/Principal | |
Peking University
Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Corporate Officer/Principal | |
China General Technology Group Holding Co., Ltd.
China General Technology Group Holding Co., Ltd. Industrial MachineryProducer Manufacturing China General Technology Group Holding Co Ltd. engages in the operation as a state-owned investment holding company specializing in distribution of industrial equipment and medical devices. It focuses on the development of three core businesses: advanced manufacturing and technical service consulting, medicine and medical health, and trade and engineering contracting. It is divided into eight sub-fields, such as equipment manufacturing, new materials, inspection and certification, medicine, medical, health, engineering contracting, and trade. The company was founded on March 18, 1998 and is headquartered in Beijing, China. | Industrial Machinery | Chief Tech/Sci/R&D Officer | |
University of Toronto | College/University | Doctorate Degree | |
University of Western Ontario | College/University | Graduate Degree | |
McMaster University | College/University | Masters Business Admin | |
C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Shanghai Likang Disinfectant High-Tech Co. Ltd.
Shanghai Likang Disinfectant High-Tech Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Linkwell Corp., Shanghai Likang Disinfectant High-Tech Co. Ltd. develops, manufactures, and distributes disinfectant products for the healthcare industry. The company is based in Shanghai, China. Shanghai Likang Disinfectant High-Tech Co. was acquired by Linkwell Tech Group, Inc. on June 30, 2004. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Leicester | College/University | Masters Business Admin | |
LINKWELL CORPORATION | Packaged Software | Chief Executive Officer Chief Operating Officer | |
Zacks Investment Research, Inc.
Zacks Investment Research, Inc. Investment ManagersFinance Founded by Len Zacks in 1978, Zacks Investment Research, Inc. is an SEC-registered broker/dealer and investment research firm headquartered in Chicago, Illinois with an office in Irvine, California. The firm is principally owned by The Greenwood Trust. Zacks makes both short-term and long-term investment recommendations using the following investment styles: aggressive growth, growth/income, momentum, value, technicals and options. Zack Investment Research employs the Zacks Rank, a 100% a peerless stock rating system that is based on a quantitative model that includes the use of four factors including as earnings estimate revisions and earnings surprises. Stocks are classified into five groups, ranging from 'Strong Buy' to 'Strong Sell.' Zacks Rank is completely mathematical and focuses only on the math and whether the math predicts that a stock's price will rise. It is a short-term indicator of stock performance that is effective for 1 to 3 months. The Zacks Recommendation process begins with a new quantitative model that employs the Zacks Rank. The firm then utilizes qualitative insights to develop a unique recommendation based on a 6 month time horizon. Zacks Investment Research provides coverage primarily on the following sectors: (1) manufacturers of electrical components (2) photo optics/lasers (3) HPC computing platforms (4) manufacturers and distributors of textiles (5) information technology (6) independent oil and gas companies involved in the exploration, development and acquisition of crude oil and natural gas (6) providers of docking, manipulator and wafer probing interface products for semiconductor and ATE manufacturers (7) companies that design and manufacture oscilloscopes, serial data analyzers and protocol analyzers to test, measure and analyze electronic signals (8) manufacturers of branded toys, collectibles, hobby or infant products and (9) financial services companies. | Investment Managers | Analyst-Equity | |
China Europe International Business School | College/University | Masters Business Admin | |
Fudan University | College/University | Corporate Officer/Principal | |
Chinese Academy of Sciences | College/University | Doctorate Degree | |
Medipharm Biotech Pharmaceutical Co. Ltd.
Medipharm Biotech Pharmaceutical Co. Ltd. BiotechnologyHealth Technology Part of Hybrid Kinetic Group Ltd., Medipharm Biotech Pharmaceutical Co. Ltd. is an investment holding Bermudian company with interests in the biopharmaceutical industry. The CEO of the company is Dianwen Ju. Medipharm Biotech Pharmaceutical Co. was acquired by Hybrid Kinetic Group Ltd. from Medibiotech Co., Inc. on July 20, 2007. | Biotechnology | Chief Executive Officer | |
Shanghai Chengqi Private Equity Fund Management Co., Ltd.
Shanghai Chengqi Private Equity Fund Management Co., Ltd. Investment ManagersFinance Shanghai Liuhe Investment Co., Ltd. engages in the provision of private equity fund management services. Its investment area covers securities investment, quantitative investment, fixed income investment, listed companies private equity investment, and venture capital. The company was founded on August 25, 2004 and is headquartered in Shanghai, China. | Investment Managers | Corporate Officer/Principal | |
Shanghai Sunway Biotech Co., Ltd.
Shanghai Sunway Biotech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Sunway Biotech Co., Ltd. is a private company founded in 1995 that develops, manufactures, and supplies biotherapeutics and pharmaceuticals. The company is based in Shanghai, China. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Shanghai Pharmaceutical Industry Association | Director/Board Member | ||
Fourth Military Medical University | College/University | Undergraduate Degree | |
GUANGDONG TAIANTANG PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Peking University Health Science Center | College/University | Corporate Officer/Principal | |
BEIJING LEADMAN BIOCHEMISTRY CO.,LTD. | Medical Specialties | Investor Relations Contact | |
Shanghai Pharmaceutical Association | Director/Board Member | ||
WBL Properties (China) Pte Ltd. | Corporate Officer/Principal | ||
Shanghai Zhongyu Pharmaceutical Technology Co., Ltd.
Shanghai Zhongyu Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Zhongyu Pharmaceutical Technology Co., Ltd. engages in the research and development of medicine and cosmetic products. Its business activities include sale of medical devices, environmental protection equipment, health supplies and cosmetics; business management; and advertising services. The company was founded on November 6, 1996 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Chairman | |
Shanghai Huatuo Pharmaceutical Technology Development Co. Ltd.
Shanghai Huatuo Pharmaceutical Technology Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Huatuo Pharmaceutical Technology Development Co. Ltd. is a Chinese company that focuses on researching, developing, manufacturing, and selling pharmaceutical products. The private company is based in Huangpu, China. | Pharmaceuticals: Major | Director/Board Member | |
AUTEK CHINA INC. | Medical Specialties | Director/Board Member | |
WUXI BIOLOGICS (CAYMAN) INC. | Biotechnology | Chief Operating Officer | |
China Jiuhao Health Industry Co. Ltd. | Corporate Officer/Principal | ||
FOSUN TOURISM GROUP | Other Consumer Services | President | |
Zacks Investment Research, Inc. (Small Cap Research) | Investment Managers | Analyst-Equity | |
MABPHARM LIMITED | Miscellaneous Commercial Services | Chief Executive Officer | |
Taizhou Mabtech Pharmaceutical Co. Ltd. | Chief Executive Officer | ||
IVD MEDICAL HOLDING LIMITED | Medical Distributors | Director/Board Member | |
Shanghai Immunology Association | President | ||
Taizhou Mabtech Biotechnology Ltd. | Corporate Officer/Principal | ||
Shanghai Zhangjiang Biotechnology Co. Ltd. | Corporate Officer/Principal | ||
Jiangsu Maitai Shouchuang Biotechnology Co. Ltd. | Corporate Officer/Principal | ||
IMMUNOTECH BIOPHARM LTD | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Tongji University School of Medicine | College/University | Corporate Officer/Principal | |
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. | Medical Distributors | Director/Board Member |
Statistics
International
China | 34 |
United States | 6 |
Singapore | 4 |
Canada | 4 |
United Kingdom | 2 |
Sectoral
Health Technology | 14 |
Consumer Services | 14 |
Finance | 6 |
Distribution Services | 4 |
Technology Services | 3 |
Operational
Corporate Officer/Principal | 21 |
Chairman | 17 |
Undergraduate Degree | 15 |
Director/Board Member | 13 |
Graduate Degree | 11 |
Most connected contacts
Insiders | |
---|---|
Zhong Xi Cai | 17 |
Hao Wang | 7 |
Xue Lian Bian | 6 |
Yu Zhang | 6 |
Ming Long Cao | 5 |
Grant Zeng | 5 |
Qin Zhu | 5 |
Qing Xu | 4 |
He Jubin | 4 |
Tong Yong | 4 |
Dianwen Ju | 4 |
Yuan Ying Jiang | 4 |
Ren Qian Zhong | 3 |
Peng Chen | 2 |
Tong Ge Huang | 2 |
- Stock Market
- Insiders
- Wen Bin Wang
- Company connections